Concepedia

Minimal residual disease detection in childhood precursor–B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study

Michael J. Borowitz, DJ Pullen, Jonathan J. Shuster, David S. Viswanatha, Karen Dyer Montgomery, Cheryl L. Willman, Bruce M. Camitta

Leukemia · 2003 · 143 citations · 47 references

DOI

Concepts

References

47

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Jacques J. M. van Dongen, Taku Seriu, E. Renate Panzer-Grümayer et al. · The Lancet · 1998 · 961 citations

, , +14

Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

Hélène Cavé, Jutte van der Werff ten Bosch, Stefan Suciu et al. · New England Journal of Medicine · 1998 · 775 citations · Full text

, , +17

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

Sheila Shurtleff, Arjan Buijs, F G Behm et al. · PubMed · 1995 · 561 citations

, , +9

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

Elaine Coustan‐Smith, José Sancho, Michael L. Hancock et al. · Blood · 2000 · 473 citations

, , +15

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

Elaine Coustan‐Smith, Frederick G. Behm, Joaquín Sánchez et al. · The Lancet · 1998 · 454 citations

, , +16